Search
for
Sort by
Research 91–120 of 747
- Erosive pustular dermatosis of the scalp: causes and treatments
- Local Corticosteroids for Alopecia Areata: A Narrative Review
- Therapeutic Efficacy of Combination Therapy Using Oral Cyclosporine with a Dietary Supplement (Pantogar®) in Twenty-Nail Dystrophy
- Therapeutic Application of Microsponges-based Drug Delivery Systems
- Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
- Formulation And Evaluation Of Emulgel Of An Antifungal Drug For Topical Drug Delivery
- Oxidative Stress in Alopecia Areata and its Association with Disease Severity, Treatment and Autoimmunity
- The genetically programmed hair growth cycle and alopecia: what is there to know?
- Management of Toxicities of Targeted Therapies
- Current and future pharmacotherapy for alopecia areata
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Janus Kinase inhibitors in dermatology: a review
- A REVIEW ON COLOURFUL MEHENDI: THE RISK OF PARAPHENYLENEDIAMINE
- Scarring Alopecia
- Lipid nanocarriers as innovative strategies for hair regrowth
- Atypical Morphological Patterns of Topical Steroid-Modified Dermatophytosis: A Cross-Sectional Study in South Asia
- Use of Castor Oil in Dermatology: A Narrative Review
- COMPARATIVE EFFICACY OF TOPICAL CLOBETASOL PROPIONATE 0.05% OINTMENT AND TOPICAL TACROLIMUS 0.1% OINTMENT IN THE TREATMENT OF ALOPECIA AREATA
- Studying the relationship betweenSerum Copper levels and Vitamin D in Alopecia Areata patients with Controls in India
- Retrospektive Analyse von Wirksamkeit, Sicherheit, prognostischen Parametern und Faktoren der Lebensqualität bei der topischen Immuntherapie der Alopecia areata mit Diphenylcyclopropenon
- Comparing the Efficiency of Elidel Cream and Elidel Accompanied With Tretinoin Cream in Treatment of Alopecia Areata
- Subject Index
- Reporting on Adverse Clinical Events
- Alopecia
- Dermatologic therapy: December 1986 to December 1987
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part I Topical and Device-based Treatment
- Liposomal systems as drug delivery vehicles for dermal and transdermal applications
- Lupus erythematosus: systemic and cutaneous manifestations
- Psoriasis of the Scalp
- Psoriatic Skin Lesions Induced by Certolizumab Pegol